United States: SAMHSA Final Rule Codifies Opioid Treatment Program Telehealth And Take-Home Medication Flexibilities - Goodwin Procter LLP

Mondaq

11 Mar 2024 0 shares 1 views

United States: SAMHSA Final Rule Codifies Opioid Treatment Program Telehealth And Take-Home Medication Flexibilities - Goodwin Procter LLP

Mondaq

Published 11 Mar 2024

On February 2, 2024, the Department of Health and Human Services (HHS) issued a Final Rule that expands access to medications for the treatment of opioid use disorder (OUD) via telehealth modalities and

Full Article

United States: FDA's Laboratory Developed Test (LDT) Final Rule Under OIRA Review; Subcommittee On Health To Hold Hearing On Regulation Of Diagnostic Tests - Goodwin Procter LLP

On March 1, 2024, the Office of Information and Regulatory Affairs ("OIRA"), Office of Management and Budget ("OMB"), Executive..

Mondaq 19 Mar 2024

United States: SAMHSA Final Rule Codifies Opioid Treatment Program Telehealth And Take-Home Medication Flexibilities - Goodwin Procter LLP

United States: SAMHSA Final Rule Codifies Opioid Treatment Program Telehealth And Take-Home Medication Flexibilities - Goodwin Procter LLP

You might like

Related news coverage

United States: FDA's Laboratory Developed Test (LDT) Final Rule Under OIRA Review; Subcommittee On Health To Hold Hearing On Regulation Of Diagnostic Tests - Goodwin Procter LLP

Advertisement